MacroGenics Overview

Life ScienceCompany

Was MacroGenics formerly PE-backed?

Yes. MacroGenics was formerly owned by 2 private investors.

Where is MacroGenics headquartered?

MacroGenics is headquartered in Rockville, Maryland.

What is MacroGenics’ revenue?

MacroGenics disclosed revenue of 148M USD for 2024 and 57M USD for 2023.

How many employees does MacroGenics have?

MacroGenics has 341 employees.

What sector is MacroGenics in?

MacroGenics is a life science company.

When was MacroGenics founded?

MacroGenics was founded in 2000.

MacroGenics

MacroGenics, Inc.

9704 Medical Center Drive,
Rockville, Maryland 20850
United States,
(301) 251-5172
www.macrogenics.com

MacroGenics is a developer of monoclonal antibodies and vaccines in the areas of oncology, autoimmunity, and infectious disease. The Company has an anti-CD3 monoclonal antibody in Phase III clinical development for type 1 diabetes. MacroGenics has a deep pipeline of clinical and preclinical antibodies enabled by its proprietary Fc-engieering and diabody capabilities. MacroGenics was founded in 2000 and is based in Rockville, Maryland.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # - - - - 1 - 1
  1

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.